PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: HCI-013EI

Model Contact
Model: HCI-013EI
Model Contact: Alana Welm
Institution: HCI Breast PDX Program
Email: Alana.Welm@hci.utah.edu

Patient Information
Clinical Timeline

Color Keys:
 
 Positive
 
 Negative
 
 N/A

Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: HCI-013EI

Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV


Histology Information for Model: HCI-013EI
There are no histology images for this model.













Metastasis Information for Model: HCI-013EI
 
Patient
PDX
Abdomen
Adrenal gland
Bone
Bones
Brain
CTC
Chest
Chest wall
Contralateral Breast
Dura
Fallopian Tubes
Head
Kidney
Liver
Lung
Lymph node
Lymph nodes
Neck
Ovary
Pancreas
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural effusion
Shoulder
Skin
Spine
Spleen
Thoracic Spine
Thymus

Patient Treatment Information for Model: HCI-013EI

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical Response
11LeuprolideNeoadjuvant46.551.51825 daysProgressive disease
12LetrozoleNeoadjuvant46.550.581489 daysProgressive disease
13Zolendronic Acid Neoadjuvant46.553.832675 daysProgressive disease
14Radiation BoneNeoadjuvant50.6750.7529 daysProgressive disease
15TamoxifenNeoadjuvant50.5851.25245 daysProgressive disease
17AromasinNeoadjuvant51.3351.562 daysProgressive disease
18Cyclophosphamide, FluorouracilNeoadjuvant51.4151.4826 daysProgressive disease
19MethotrexateNeoadjuvant51.551.7591 daysProgressive disease
20CapcitabineNeoadjuvant51.9152.25124 daysProgressive disease
21PaclitaxelNeoadjuvant52.2552.75183 daysProgressive disease
23Abraxane Neoadjuvant52.7552.9158 daysProgressive disease
24Radiation Spine Neoadjuvant52.2552.3329 daysProgressive disease
25Radiation spineNeoadjuvant52.7552.8329 daysProgressive disease
27Doxorubicin Neoadjuvant52.9153.75307 daysProgressive disease
29Carboplatin, Gemcitabine Neoadjuvant53.8353.9129 daysProgressive disease













Please wait...